MYGN
Price
$8.00
Change
-$0.41 (-4.88%)
Updated
Apr 4, 04:43 PM (EDT)
Capitalization
1.93B
27 days until earnings call
PHG
Price
$22.49
Change
-$1.37 (-5.74%)
Updated
Apr 4, 02:48 PM (EDT)
Capitalization
18.21B
32 days until earnings call
Ad is loading...

MYGN vs PHG

Header iconMYGN vs PHG Comparison
Open Charts MYGN vs PHGBanner chart's image
Myriad Genetics
Price$8.00
Change-$0.41 (-4.88%)
Volume$2.1K
Capitalization1.93B
Koninklijke Philips
Price$22.49
Change-$1.37 (-5.74%)
Volume$1.73K
Capitalization18.21B
MYGN vs PHG Comparison Chart
Loading...
MYGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MYGN vs. PHG commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MYGN is a Hold and PHG is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (MYGN: $8.41 vs. PHG: $23.86)
Brand notoriety: MYGN and PHG are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: MYGN: 84% vs. PHG: 230%
Market capitalization -- MYGN: $1.93B vs. PHG: $18.21B
MYGN [@Medical Specialties] is valued at $1.93B. PHG’s [@Medical Specialties] market capitalization is $18.21B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MYGN’s FA Score shows that 1 FA rating(s) are green whilePHG’s FA Score has 1 green FA rating(s).

  • MYGN’s FA Score: 1 green, 4 red.
  • PHG’s FA Score: 1 green, 4 red.
According to our system of comparison, PHG is a better buy in the long-term than MYGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MYGN’s TA Score shows that 4 TA indicator(s) are bullish while PHG’s TA Score has 4 bullish TA indicator(s).

  • MYGN’s TA Score: 4 bullish, 5 bearish.
  • PHG’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, PHG is a better buy in the short-term than MYGN.

Price Growth

MYGN (@Medical Specialties) experienced а -8.79% price change this week, while PHG (@Medical Specialties) price change was -7.12% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -5.51%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was -1.14%.

Reported Earning Dates

MYGN is expected to report earnings on May 01, 2025.

PHG is expected to report earnings on May 06, 2025.

Industries' Descriptions

@Medical Specialties (-5.51% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHG($18.2B) has a higher market cap than MYGN($1.93B). PHG YTD gains are higher at: -5.766 vs. MYGN (-38.658). PHG has higher annual earnings (EBITDA): 1.04B vs. MYGN (-197.4M). PHG has more cash in the bank: 1.87B vs. MYGN (141M). MYGN has less debt than PHG: MYGN (152M) vs PHG (7.61B). PHG has higher revenues than MYGN: PHG (18.2B) vs MYGN (753M).
MYGNPHGMYGN / PHG
Capitalization1.93B18.2B11%
EBITDA-197.4M1.04B-19%
Gain YTD-38.658-5.766670%
P/E RatioN/A29.76-
Revenue753M18.2B4%
Total Cash141M1.87B8%
Total Debt152M7.61B2%
FUNDAMENTALS RATINGS
MYGN vs PHG: Fundamental Ratings
MYGN
PHG
OUTLOOK RATING
1..100
6554
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
3
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9492
PRICE GROWTH RATING
1..100
9258
P/E GROWTH RATING
1..100
263
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PHG's Valuation (3) in the Electronic Production Equipment industry is significantly better than the same rating for MYGN (97) in the Biotechnology industry. This means that PHG’s stock grew significantly faster than MYGN’s over the last 12 months.

PHG's Profit vs Risk Rating (100) in the Electronic Production Equipment industry is in the same range as MYGN (100) in the Biotechnology industry. This means that PHG’s stock grew similarly to MYGN’s over the last 12 months.

PHG's SMR Rating (92) in the Electronic Production Equipment industry is in the same range as MYGN (94) in the Biotechnology industry. This means that PHG’s stock grew similarly to MYGN’s over the last 12 months.

PHG's Price Growth Rating (58) in the Electronic Production Equipment industry is somewhat better than the same rating for MYGN (92) in the Biotechnology industry. This means that PHG’s stock grew somewhat faster than MYGN’s over the last 12 months.

MYGN's P/E Growth Rating (2) in the Biotechnology industry is somewhat better than the same rating for PHG (63) in the Electronic Production Equipment industry. This means that MYGN’s stock grew somewhat faster than PHG’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MYGNPHG
RSI
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
67%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
65%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
57%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
56%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
61%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
60%
Advances
ODDS (%)
Bullish Trend 19 days ago
75%
Bullish Trend 19 days ago
61%
Declines
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
61%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
59%
Aroon
ODDS (%)
Bearish Trend 2 days ago
78%
N/A
View a ticker or compare two or three
Ad is loading...
MYGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNK24.990.20
+0.81%
Cinemark Holdings
BSAC23.12-0.17
-0.73%
Banco Santander-Chile
AGRI1.26-0.02
-1.56%
AgriFORCE Growing Systems Ltd
LCTX0.42-0.02
-4.55%
Lineage Cell Therapeutics
XRX4.18-0.73
-14.87%
Xerox Holdings Corp

PHG and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHG has been loosely correlated with RYLPF. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if PHG jumps, then RYLPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHG
1D Price
Change %
PHG100%
-3.95%
RYLPF - PHG
56%
Loosely correlated
N/A
SMMNY - PHG
34%
Loosely correlated
-6.12%
MYGN - PHG
32%
Poorly correlated
-4.43%
OLYMY - PHG
32%
Poorly correlated
-2.90%
RVTY - PHG
30%
Poorly correlated
-5.59%
More